In accordance with the Food and Drug Administration's change order for drug manufacturing (import) product approval (Drug Management Division-No. 8185, effective date 2009.8.19), the precautions for using Alprin tablets have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.